Protein Science
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print February 6, 2004, 10.1110/ps.03457204
Protein Science (2004), 13:586-595. Published by Cold Spring Harbor Laboratory Press. Copyright © 2004 The Protein Society
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ps.03457204v1
13/3/586    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baskakov, I. V.
Right arrow Articles by Prusiner, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baskakov, I. V.
Right arrow Articles by Prusiner, S. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The peculiar nature of unfolding of the human prion protein

Ilia V. Baskakov1, Giuseppe Legname3, Zygmunt Gryczynski2 and Stanley B. Prusiner2,4

1 Medical Biotechnology Center, University of Maryland Biotechnology Institute, Baltimore, Maryland 21201, USA
2 Center for Fluorescent Spectroscopy, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
3 Institute for Neurodegenerative Diseases, Department of Neurology and
4 Institute for Neurodegenerative Diseases, Departments of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California 94143, USA

(RECEIVED September 24, 2003; FINAL REVISION October 31, 2003; ACCEPTED November 10, 2003)



Abstract

Spontaneous conformational transition of the prion protein from an {alpha}-helical isoform to a {beta}-sheet-rich isoform underlies the pathogenesis of sporadic prion diseases. To study the rate-limiting steps of spontaneous conversion, the formation of amyloid fibrils by the recombinant human PrP C-terminal fragment spanning residues 90–231 (recPrP) was monitored in the presence of urea. The kinetics of spontaneous fibril formation displayed sigmoidal behavior involving a lag phase. The shortest lag phase was observed at partially denaturing conditions, close to the concentration of urea corresponding to the middle point of unfolding. This result indicates that unfolding intermediates may be important for the conversion. To test whether unfolding intermediates are formed, we employed size-exclusion chromatography and circular dichroism spectroscopy to monitor urea denaturation of recPrP. Both techniques showed a single sigmoidal transition with very similar thermodynamic parameters of denaturation and that the transition can be described by a simple equilibrium between folded and denatured states. Detailed analyses of data, however, revealed that the dimensions of both the native and denatured species gradually increases with urea. Expansion of the native species is also accompanied by an increase in efficiency of the energy transfer from a single Trp residue to 1-anilinonaphthalene-8-sulfonate dye as measured by fluorescence. These data illustrate that thermodynamic character of the native ensemble changes gradually with environmental conditions. Such behavior is consistent with the thermodynamically variable model, and may be linked to the ability of PrP to adopt distinct abnormal conformations under pathologic conditions.

Keywords: prion protein; conformational transition; amyloid fibrils; unfolding intermediates; size exclusion chromatography

Abbreviations: 1 PrPC, cellular isoform of the prion protein • PrPSc, disease-associated isoform of the prion protein • recPrP, recombinant prion protein • {alpha}-recPrP, {alpha}-helical monomeric form of recPrP • ANS, 1-anilinonaphthalene-8-sulfonate • CD, circular dichroism • recPrP106, recombinant prion protein of 106 residues • ThT, Tioflavin T • GndHCl, guanidine hydrochloride • SEC, size-exclusion chromatography


Reprint requests to: Ilia V. Baskakov, Medical Biotechnology Center, University of Maryland Biotechnology Institute, 725 W. Lombard Street, Baltimore, MD 21201, USA; e-mail: Baskakov{at}umbi.umd.edu; fax: (410) 706-8184.

Article published online ahead of print. Article and publication date are at http://www.proteinscience.org/cgi/doi/10.1110/ps.03457204.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Makarava and I. V. Baskakov
The Same Primary Structure of the Prion Protein Yields Two Distinct Self-propagating States
J. Biol. Chem., June 6, 2008; 283(23): 15988 - 15996.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Sun, L. Breydo, N. Makarava, Q. Yang, O. V. Bocharova, and I. V. Baskakov
Site-specific Conformational Studies of Prion Protein (PrP) Amyloid Fibrils Revealed Two Cooperative Folding Domains within Amyloid Structure
J. Biol. Chem., March 23, 2007; 282(12): 9090 - 9097.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Gerber, A. Tahiri-Alaoui, P. J. Hore, and W. James
Oligomerization of the Human Prion Protein Proceeds via a Molten Globule Intermediate
J. Biol. Chem., March 2, 2007; 282(9): 6300 - 6307.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Tahiri-Alaoui, V. L. Sim, B. Caughey, and W. James
Molecular Heterosis of Prion Protein beta-Oligomers: A POTENTIAL MECHANISM OF HUMAN RESISTANCE TO DISEASE
J. Biol. Chem., November 10, 2006; 281(45): 34171 - 34178.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
K. N. Frankenfield, E. T. Powers, and J. W. Kelly
Influence of the N-terminal domain on the aggregation properties of the prion protein
Protein Sci., August 1, 2005; 14(8): 2154 - 2166.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
J. Novakofski, M. S. Brewer, N. Mateus-Pinilla, J. Killefer, and R. H. McCusker
Prion biology relevant to bovine spongiform encephalopathy
J Anim Sci, June 1, 2005; 83(6): 1455 - 1476.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
A. Tahiri-Alaoui and W. James
Rapid formation of amyloid from {alpha}-monomeric recombinant human PrP in vitro
Protein Sci., April 1, 2005; 14(4): 942 - 947.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
J. R. Kim, A. Muresan, K. Y. C. Lee, and R. M. Murphy
Urea modulation of {beta}-amyloid fibril growth: Experimental studies and kinetic models
Protein Sci., November 1, 2004; 13(11): 2888 - 2898.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
M. Bozzi, E. Di Stasio, D. O. Cicero, B. Giardina, M. Paci, and A. Brancaccio
The effect of an ionic detergent on the natively unfolded {beta}-dystroglycan ectodomain and on its interaction with {alpha}-dystroglycan
Protein Sci., September 1, 2004; 13(9): 2437 - 2445.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The Protein Society.